CLINICAL PHARMACOKINETICS OF THE SALICYLATES

被引：247
作者：
NEEDS, CJ [1 ]
BROOKS, PM [1 ]
机构：
[1] ROYAL N SHORE HOSP, DEPT RHEUMATOL, ST LEONARDS, NSW 2065, AUSTRALIA
来源：
CLINICAL PHARMACOKINETICS | 1985年 / 10卷 / 02期
关键词：
D O I：
10.2165/00003088-198510020-00004
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：164 / 177
页数：14
相关论文
共 145 条
[1]  
ALI MA, 1969, CLIN CHEM, V15, P1027
[2]  
Anderson JAD, 1977, TXB ADVERSE DRUG REA, P217
[3]   CLINICAL MEASUREMENT OF ANTI-INFLAMMATORY EFFECTS OF SALICYLATES IN RHEUMATOID ARTHRITIS [J].
BOARDMAN, PL ;
HART, FD .
BMJ-BRITISH MEDICAL JOURNAL, 1967, 4 (5574) :264-+
[4]   SALICYLATE METABOLITE KINETICS AFTER SEVERAL SALICYLATES [J].
BOCHNER, F ;
GRAHAM, GG ;
CHAM, BE ;
IMHOFF, DM ;
HAAVISTO, TM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :266-275
[5]   KINETICS OF ELIMINATION OF SALICYLIC ACID AND FORMATION OF GENTISIC ACID [J].
BOREHAM, DR ;
MARTIN, BK .
BRITISH JOURNAL OF PHARMACOLOGY, 1969, 37 (01) :294-&
[6]  
BORGA O, 1976, CLIN PHARMACOL THER, V20, P464
[7]   BIOAVAILABILITY OF ACETYLSALICYLIC-ACID AND SALICYLIC-ACID FROM RAPID-RELEASE AND SLOW-RELEASE FORMULATIONS, AND IN COMBINATION WITH DIPYRIDAMOL [J].
BRANTMARK, B ;
WAHLINBOLL, E ;
MELANDER, A .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (04) :309-314
[8]  
BRODIE BB, 1960, J PHARMACOL EXP THER, V130, P20
[9]   FLURBIPROFEN-ASPIRIN INTERACTION - DOUBLE-BLIND CROSSOVER STUDY [J].
BROOKS, PM ;
KHONG, TK .
CURRENT MEDICAL RESEARCH AND OPINION, 1977, 5 (01) :53-57
[10]  
BROOKS PM, 1978, BRIT J CLIN PHARMACO, V5, P337, DOI 10.1111/j.1365-2125.1978.tb01717.x
12345678910